Rakuten Investment Management Inc. Makes New $2.11 Million Investment in Astera Labs, Inc. $ALAB

Rakuten Investment Management Inc. acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 10,781 shares of the company’s stock, valued at approximately $2,111,000.

Several other large investors also recently bought and sold shares of ALAB. Grove Bank & Trust purchased a new position in shares of Astera Labs in the third quarter worth $68,000. Bernard Wealth Management Corp. acquired a new position in Astera Labs in the 2nd quarter worth approximately $36,000. Clearstead Trust LLC raised its position in Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after buying an additional 461 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after acquiring an additional 194 shares during the period. Finally, Manchester Capital Management LLC lifted its stake in Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after acquiring an additional 283 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other news, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the sale, the director directly owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. The trade was a 8.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jitendra Mohan sold 90,459 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at $301,015,680.42. The trade was a 4.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 576,936 shares of company stock worth $87,409,540 in the last quarter. 12.50% of the stock is owned by insiders.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $169.66 on Friday. The business’s 50 day moving average price is $161.80 and its 200-day moving average price is $168.80. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The firm has a market capitalization of $28.66 billion, a price-to-earnings ratio of 152.85, a price-to-earnings-growth ratio of 2.41 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. During the same quarter in the previous year, the firm earned $0.23 EPS. The firm’s revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. BNP Paribas Exane initiated coverage on Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating on the stock. Morgan Stanley reiterated an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Bank of America assumed coverage on Astera Labs in a report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price target for the company. Finally, Citigroup reaffirmed an “outperform” rating on shares of Astera Labs in a research note on Tuesday, December 9th. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $190.63.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.